No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Bausch & Lomb Edges Higher After Confirming Sales Process
Bausch Health Says Board Authorized Management To Explore Potential Sale Of Subsidiary Bausch + Lomb; Says Process Is Ongoing. No Decision Has Been Reached
Bausch + Lomb Brief: Says a Potential Sale Is One of Several Options Being Explored to Complete a Full Separation From Bausch Health
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
Bausch + Lomb Shares Down on Report That Potential Buyer May Back Out
Toronto Stocks Rise, BOC Cuts Rate by 50 Basis Points; Bausch Health Shares Down as Potential Buyer Balks